The medical program of CLL is very heterogeneous, ranging from a reasonably asymptomatic disorder that could even regress spontaneously to a progressive disorder that ultimately brings about the patient’s Loss of life, so there has normally been impressive interest in identifying the prognosis of unique individuals. While several prognostic marke